Resultados de la búsqueda 651-660 of 4524 for Blood factor II
This is a phase II multi-center study of nab-paclitaxel, gemcitabine and cisplatin (NGC triple regimen) as preoperative therapy in potentially resectable ...
The purpose of part two of this study is to evaluate safety and tolerability and evidence of anticancer activity of Q901 as monotherapy and in combination with ...
In Part 2 Cohort 1, an expansion phase at the established RP2D will be undertaken in participants with selected advanced solid tumors. In Part 2 Cohort 2, a ...
... factors known to impact risk such as age, weight ... These include but are not limited to improvements in: (i) receiver coils; (ii) ... (2) evaluate the ...
This phase II trial tests whether an exercise ... H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of increasing immune response ...
Radiotracer side effects · A metallic taste in the mouth. · An area of blood called a hematoma that forms around the spot where the needle goes into the skin.
2. A second purpose of this study is to obtain blood and tissue samples from participants having or at risk for developing cancer of the liver or bile ducts or ...
The purpose of this study is to compare the effects, good and/or bad of two treatment methods on subjects and their cancer. Proton beam radiation therapy is one ...
... 2 or 3 meningioma as measured by 6-month PFS rate. ... Finally, it will allow characterization of patient selection factors ... Finally, it will allow ...
In the phase II part, to evaluate the preliminary antitumor activity of two ... blood DNA markers for inflammatory bowel disease ... blood. Blood And ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?